Literature DB >> 21941216

Life-threatening pneumonia caused by macrolide-resistant Mycoplasma pneumoniae.

Yu-Chia Hsieh, Kuo-Chien Tsao, Chung-Guei Huang, Suxiang Tong, Jonas M Winchell, Yhu-Chering Huang, Shao-Hsuan Shia, Shen-Hao Lai, Tzou-Yien Lin.   

Abstract

Two siblings had pneumonia caused by macrolide-resistant Mycoplasma pneumoniae as determined by polymerase chain reaction and serology. One of them developed adult respiratory distress syndrome and required extracorporeal membrane oxygenation therapy. This report highlights the need for studies to evaluate the optimal treatment in severe cases of macrolide-resistant M. pneumoniae pneumonia.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 21941216     DOI： 10.1097/INF.0b013e318234597c

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN： 0891-3668            Impact factor:   2.129


  10 in total

Review 1.  Mycoplasma pneumoniae from the Respiratory Tract and Beyond.

Authors:  Ken B Waites; Li Xiao; Yang Liu; Mitchell F Balish; T Prescott Atkinson
Journal:  Clin Microbiol Rev       Date:  2017-07       Impact factor: 26.132

2.  Fulminant Mycoplasma Infection Requiring ECMO in a Previously Healthy Child: Case Report and Review.

Authors:  Catherine S Heith; Janet R Hume; Marie E Steiner; Gwenyth A Fischer
Journal:  J Pediatr Intensive Care       Date:  2017-12-18

3.  Predictive value of C-reactive protein in response to macrolides in children with macrolide-resistant Mycoplasma pneumoniae pneumonia.

Authors:  Young Ho Seo; Jang Su Kim; Sung Chul Seo; Won Hee Seo; Young Yoo; Dae Jin Song; Ji Tae Choung
Journal:  Korean J Pediatr       Date:  2014-04-30

4.  Early diagnosis and appropriate respiratory support for Mycoplasma pneumoniae pneumonia associated acute respiratory distress syndrome in young and adult patients: a case series from two centers.

Authors:  Lin Ding; Yu Zhao; Xuyan Li; Rui Wang; Ying Li; Xiao Tang; Bing Sun; Hangyong He
Journal:  BMC Infect Dis       Date:  2020-05-24       Impact factor: 3.090

5.  Macrolide-Resistant Mycoplasma pneumoniae Infections in Pediatric Community-Acquired Pneumonia.

Authors:  Yu-Chin Chen; Wei-Yun Hsu; Tu-Hsuan Chang
Journal:  Emerg Infect Dis       Date:  2020-07       Impact factor: 6.883

6.  Inhibition of Mycoplasma pneumoniae growth by FDA-approved anticancer and antiviral nucleoside and nucleobase analogs.

Authors:  Ren Sun; Liya Wang
Journal:  BMC Microbiol       Date:  2013-08-06       Impact factor: 3.605

Review 7.  Mycoplasma pneumoniae: A Potentially Severe Infection.

Authors:  Bharat Bajantri; Sindhaghatta Venkatram; Gilda Diaz-Fuentes
Journal:  J Clin Med Res       Date:  2018-06-04

8.  Therapeutic Efficacy and Safety of Prolonged Macrolide, Corticosteroid, Doxycycline, and Levofloxacin against Macrolide-Unresponsive Mycoplasma pneumoniae Pneumonia in Children.

Authors:  Seok Gyun Ha; Kyung Jin Oh; Kwang-Pil Ko; Yong Han Sun; Eell Ryoo; Hann Tchah; In Sang Jeon; Hyo Jeong Kim; Jung Min Ahn; Hye-Kyung Cho
Journal:  J Korean Med Sci       Date:  2018-09-18       Impact factor: 2.153

9.  Macrolide-resistant Mycoplasma pneumoniae in children in Taiwan.

Authors:  Han-Meng Wu; Kin-Sun Wong; Yhu-Chering Huang; Shen-Hao Lai; Kuo-Chien Tsao; Ya-Jhu Lin; Tzou-Yien Lin
Journal:  J Infect Chemother       Date:  2012-11-30       Impact factor: 2.211

10.  Pediatric round pneumonia.

Authors:  Yen-Lin Liu; Ping-Sheng Wu; Li-Ping Tsai; Wen-Hsin Tsai
Journal:  Pediatr Neonatol       Date:  2013-03-13       Impact factor: 2.083
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.